Light AI Inc. OHCFF

Company Overview

Light AI Inc. (OTC: OHCFF) is a technology and healthcare-focused company developing artificial intelligence-enabled diagnostic and screening solutions. Based on publicly available corporate disclosures and market filings, the company operates primarily in the digital health and medical technology sectors, with a focus on applying machine learning and mobile-device-based analytics to healthcare screening and early detection applications. Publicly available information indicates that the company’s business model centers on commercializing AI-driven software platforms and related healthcare technologies rather than large-scale manufacturing operations.

The company has positioned itself around accessible and scalable diagnostic technologies intended for broad healthcare use cases, including remote and mobile screening environments. Available public records suggest that Light AI has evolved from an earlier-stage technology and innovation platform into a company emphasizing AI-enabled healthcare applications. Some operational and historical details remain limited across major independent financial databases, and certain aspects of the company’s historical evolution are not consistently described across public sources. Data inconclusive based on available public sources.

Business Operations

Light AI’s operations appear to be concentrated in software development, artificial intelligence applications, and healthcare technology commercialization. Public disclosures indicate that the company’s activities involve proprietary AI algorithms, data analysis systems, and mobile-compatible diagnostic technologies. Revenue generation appears to be tied primarily to technology development partnerships, commercialization initiatives, licensing potential, and future healthcare deployment opportunities rather than mature recurring operating cash flow from large established product lines.

The company’s operational footprint appears to be relatively early-stage compared with larger publicly traded healthcare technology firms. Publicly available information does not clearly identify multiple large operating divisions or geographically segmented business units. There is also limited independently verified information regarding material joint ventures, large-scale subsidiaries, or major strategic manufacturing assets. Data inconclusive based on available public sources regarding significant international operating subsidiaries or major long-term commercial partnerships.

Strategic Position & Investments

Light AI’s strategic direction appears focused on expanding AI-based healthcare screening capabilities and participating in the broader growth of digital diagnostics and decentralized healthcare technologies. Public company materials indicate interest in scalable mobile-health solutions that may support earlier detection and broader access to healthcare services, particularly in settings where traditional diagnostic infrastructure may be limited. This positioning aligns with broader industry trends involving telehealth, AI-assisted diagnostics, and cloud-connected healthcare analytics.

Public disclosures reviewed through available market and corporate filings do not consistently identify major acquisitions, large investment portfolios, or extensive holdings in external portfolio companies. The company’s strategic emphasis appears more focused on internal technology development and commercialization initiatives. Available information also suggests continued interest in emerging AI applications within healthcare and medical screening, although the scale of commercialization and deployment remains difficult to independently verify through major financial reporting databases. Data inconclusive based on available public sources regarding material acquisition activity or large institutional investments.

Geographic Footprint

Light AI appears to maintain its primary corporate presence in Canada, while its publicly traded shares are accessible to investors through the U.S. OTC market under the ticker OHCFF. Available disclosures indicate that the company’s strategic focus includes technologies with potential international applicability, particularly in healthcare environments where mobile-enabled screening solutions may have broader adoption potential.

There is limited independently verified evidence of extensive operational infrastructure across multiple continents or major international production facilities. Public information suggests the company’s commercial ambitions are international in scope, but its currently verifiable operational footprint appears comparatively concentrated. Data inconclusive based on available public sources regarding material international subsidiaries, regional headquarters outside Canada, or large-scale overseas operations.

Leadership & Governance

Publicly available filings and company disclosures indicate that Light AI is governed through a standard public-company management and board structure. However, executive information available across independent financial databases and public filings is limited and not always consistently updated. Leadership communications have generally emphasized artificial intelligence innovation, healthcare accessibility, and technology commercialization strategies.

Key executives identified in available public disclosures include:

• Peter Whitehead – Chief Executive Officer
• Kevin Buchan – Chief Financial Officer

Additional executive and governance details could not be consistently verified across multiple independent public sources at the time of review. Data inconclusive based on available public sources regarding the full current executive leadership roster and broader governance structure.